Home › Viral Infections › District of Columbia › Washington
Viral Infections clinical trials in Washington, DC
12 studies for Viral Infections are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Washington D.C.
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
RecruitingPhase 1Healthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Georgetown University Medical Center, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi away
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
- Jadestone Clinical Research, Silver Spring · 7 mi away
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
RecruitingPhase 1Healthy volunteers welcome
- George Washington University, Washington D.C.
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
RecruitingPhase 1Healthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Viral Infections in Healthy and Immunocompromised Hosts
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Genetic Studies of Chronic Active Epstein-Barr Disease
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
RecruitingPhase 1
- Children's National Hospital, Washington D.C.
- National Institutes of Health (NIH), Bethesda · 7 mi away
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Boston, MA6 studies
- Houston, TX6 studies
- Hialeah, FL5 studies
- Baltimore, MD5 studies
- Atlanta, GA4 studies
- Cincinnati, OH4 studies
- Dallas, TX4 studies
- Columbus, OH4 studies
- Tampa, FL3 studies
- Worcester, MA3 studies
- Miami, FL3 studies
- Los Angeles, CA3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.